Moneycontrol
SENSEX NIFTY
you are here:

Themis Medicare Ltd.

BSE: 530199 | NSE: THEMISMED |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE083B01016 | SECTOR: Pharmaceuticals

BSE Live

Jul 10, 16:00
385.20 14.50 (3.91%)
Volume
AVERAGE VOLUME
5-Day
610
10-Day
393
30-Day
958
2,157
  • Prev. Close

    370.70

  • Open Price

    397.00

  • Bid Price (Qty.)

    365.05 (20)

  • Offer Price (Qty.)

    396.00 (100)

NSE Live

Jul 10, 15:41
383.85 9.35 (2.50%)
Volume
AVERAGE VOLUME
5-Day
4,590
10-Day
4,594
30-Day
7,284
10,205
  • Prev. Close

    374.50

  • Open Price

    375.00

  • Bid Price (Qty.)

    383.85 (500)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Themis Medicare

  • Jul 06, 2020 23:40 Source: BSE

    Themis Medicare - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31, 2020. This is for your information and record.

  • Jun 30, 2020 18:18 Source: BSE

    Themis Medicare - Closure of Trading Window

    We would like to inform you that as per the Company''''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (PIT) Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 02.04.19 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 01.07.20 and will re-open after completion of 48 hours from the declaration of financial results for the quarter ended 30.06.20 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the quarter ended 30.06.20 shall be intimated in due course. We request you to kindly take the above information on record.

  • Jun 08, 2020 14:54 Source: NSE

    Themis Medicare Limited

    Themis Medicare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.

  • Jun 08, 2020 13:53 Source: BSE

    Themis Medicare - Outcome Of Board Meeting Held On June 08, 2020

    The Board of Directors at its meeting held today, considered and approved the following matters: 1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2020. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2020 is enclosed herewith. (Annexure I) 2. Recommended dividend for Financial Year ended 31.03.2020 of Rs. 1.75/- (Re One Paise Seventy five only) per equity share having face value of Rs.10/- each, aggregating to Rs. 160.79 lacs. The payment is subject to the approval of shareholders at the ensuing AGM 3. Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2020-21. 4. Appointed Mr. Shirish Shetye of M/s. Shirish Shetye & Associates, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 50thAnnual General Meeting.

  • Jun 08, 2020 13:33 Source: BSE

    Themis Medicare - Board recommends Dividend

    Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 08, 2020, inter alia, has recommended dividend for Financial Year ended March 31, 2020 of Rs. 1.75/- (Re One Paise Seventy five only) per equity share having face value of Rs. 10/- each, aggregating to Rs. 160.79 lacs. The payment is subject to the approval of shareholders at the ensuing AGM.

  • Jun 08, 2020 13:27 Source: BSE

    Themis Medicare - Results - Financial Results For The Quarter And Year Ended March 31,2020

    1.Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2020. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2020 is enclosed herewith. (Annexure I) 2.Recommended dividend for Financial Year ended 31.03.2020 of Rs. 1.75/- (Re One Paise Seventy five only) per equity share having face value of Rs.10/- each, aggregating to Rs. 160.79 lacs. The payment is subject to the approval of shareholders at the ensuing AGM 3.Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2020-21. 4.Appointed Mr. Shirish Shetye of M/s. Shirish Shetye & Associates, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 50th Annual General Meeting.

  • Jun 02, 2020 12:42 Source: BSE

    Themis Medicare - Board Meeting Intimation for Consider Audited Financial Results And Recommending Dividend If Any On The Equity Shares Of The Company For The Financial Year 2019-20 On Monday 08.06.2020

    THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/06/2020 ,inter alia, to consider and approve 1. To consider the Audited Financial Results for the Quarter/Year ended on 31st March, 2020. 2. To consider recommending Dividend if any on the equity shares of the Company for the financial year 2019-20,

  • May 26, 2020 20:11 Source: BSE

    Themis Medicare - Compliances - Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On March 31, 2020.

    Compliance Certificate - Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on March 31, 2020.

  • May 22, 2020 17:01 Source: BSE

    Themis Medicare - Compliances- Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended 31St March, 2020

    Enclosed herewith please find Compliance Certificate issued by M/s. V. Laxman & Co Practicing Company Secretaries for the half year ended 31st March, 2020 in terms of Regulation 40(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. This may be taken as compliance under Regulation 40(9) of the Listing Regulations.

  • May 15, 2020 18:18 Source: BSE

    Themis Medicare - Shareholding for the Period Ended March 31, 2020

    Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Jun 08, 2020
Remark : Audited Results & Final Dividend